shares of Milestone Pharmaceuticals Inc (MIST) on
Milestone Pharmaceuticals, Inc. is a biopharmaceutical company. The company is headquartered in Saint-Laurent, Quebec and currently employs 23 full-time employees. The firm is focused on developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is its short-acting calcium channel blocker. The company is developing Etripamil as a nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia (PSVT), as they occur. The company is also focused on developing treatments for other indications, such as Atrial Fibrillation and Angina. Etripamil is in Phase-III development for PSVT.